faslodex
astrazeneca ab - fulvestrantas - krūties navikai - endokrininės terapija, anti-estrogenai - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. , pre - arba perimenopausal moterys, derinant gydymą su palbociclib turėtų būti kartu su liuteinizuojančio hormono atpalaiduojantis hormonas (lhrh) agonistas.
mannitol fresenius
fresenius kabi polska sp.z.o.o. - manitolis - infuzinis tirpalas - 100 g/1000 ml; 150 g/1000 ml - mannitol
methotrexate-teva
teva pharma b.v. - metotreksatas - injekcinis tirpalas - 100 mg/ml - methotrexate
acetylsalicylic acid siromed
nvt, uab - acetilsalicilo rūgštis - skrandyje neirios tabletės - 100 mg - acetylsalicylic acid
pemetrexed mylan pharma
mylan s.a.s. - pemetreksedas - milteliai infuzinio tirpalo koncentratui - 500 mg; 100 mg; 1000 mg - pemetrexed
ceftazidime kabi
fresenius kabi polska sp.z.o.o. - ceftazidimas pentahidratas - milteliai injekciniam ar infuziniam tirpalui - 1000 mg; 500 mg; 2000 mg - ceftazidime
paramax rapid
vitabalans oy - paracetamolis - tabletės - 1000 mg; 250 mg; 500 mg - paracetamol
allopurinol-ratiopharm
ratiopharm gmbh - alopurinolis - tabletės - 100 mg; 300 mg - allopurinol
medoclav forte
medochemie ltd. - amoksicilinas/klavulano rūgštis - milteliai geriamajai suspensijai - 1000 mg/200 mg; 125 mg/31,25 mg/5 ml; 250 mg/62,5 mg/5 ml - amoxicillin and beta-lactamase inhibitor
nurofen orange
reckitt benckiser (poland) s.a. - ibuprofenas - kramtomosios minkštosios kapsulės - 100 mg - ibuprofen